No Data
China Securities Co.,Ltd.: Policy encouragement + new technology promotion + overseas opportunities create new chances, maintaining a bullish outlook on the Innovative Drugs industry.
National policies encourage the development of Innovative Drugs, new technologies promote the rapid growth of the Industry, new opportunities arise for going overseas, and there is a continuous Bullish outlook for the Innovative Drugs Industry.
Sinolink: The policy inflection point is clear, suggesting to start increasing allocation in the pharmaceutical sector.
In the segmented Industry, it is recommended to focus on allocating resources to Innovative Drugs and left-side Sectors (such as Medical Device, Traditional Chinese Medicine, Consumer Medical, chain pharmacies, etc.) for opportunities in reverse situations of individual stocks as the two main lines.
Announcement Selection | Eastern Airlines' passenger turnover increased by nearly 20% last month; Zijin Mining Group and some of its affiliated enterprises were included in the UFLPA entity list.
In 2024, the Metallurgical Corporation of China saw a year-on-year decline in newly signed contracts; last month, Eastern Airlines' passenger turnover increased by nearly 20%.
China Traditional Chinese Medicine: Lower Sales, Credit Impairment Among Factors Weighing on Results
TRAD CHI MED (00570) issues a profit warning, expecting a net profit decline of 90%-100% year-on-year in 2024.
TRAD CHI MED (00570) announced that the group is expected to experience a 90%-100% year-on-year decline in net profit for 2024...
Express News | China Traditional Chinese Medicine Sees Adjusted Net Profit for Year Would Decrease by 50%-60%
933199333 : I also buy no need thank you me.